PT3965741T - Systemic formulation of a pyridinone derivate for coeliac disease - Google Patents

Systemic formulation of a pyridinone derivate for coeliac disease

Info

Publication number
PT3965741T
PT3965741T PT217207588T PT21720758T PT3965741T PT 3965741 T PT3965741 T PT 3965741T PT 217207588 T PT217207588 T PT 217207588T PT 21720758 T PT21720758 T PT 21720758T PT 3965741 T PT3965741 T PT 3965741T
Authority
PT
Portugal
Prior art keywords
pyridinone
derivate
coeliac disease
systemic formulation
systemic
Prior art date
Application number
PT217207588T
Other languages
Portuguese (pt)
Original Assignee
Dr Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Falk Pharma Gmbh filed Critical Dr Falk Pharma Gmbh
Publication of PT3965741T publication Critical patent/PT3965741T/en

Links

PT217207588T 2020-12-03 2021-04-24 Systemic formulation of a pyridinone derivate for coeliac disease PT3965741T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20211713 2020-12-03

Publications (1)

Publication Number Publication Date
PT3965741T true PT3965741T (en) 2023-09-13

Family

ID=73726551

Family Applications (1)

Application Number Title Priority Date Filing Date
PT217207588T PT3965741T (en) 2020-12-03 2021-04-24 Systemic formulation of a pyridinone derivate for coeliac disease

Country Status (1)

Country Link
PT (1) PT3965741T (en)

Similar Documents

Publication Publication Date Title
EP3316872A4 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP3706720A4 (en) Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
EP3870261C0 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
IL285872A (en) Applicator for oral administration of a swallowable object to a patient
IL266034A (en) Novel pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases
EP4106854A4 (en) Injection of a therapeutic formulation into a wall of the gastrointestinal tract
SI3965741T1 (en) Systemic formulation of a pyridinone derivate for coeliac disease
PT3965741T (en) Systemic formulation of a pyridinone derivate for coeliac disease
EP3700625A4 (en) Intracavitary applicator for a medical procedure
GB202010230D0 (en) Pharmaceutical formulation
HUE063466T2 (en) Systemic formulation of a pyridinone derivate for tg2-related diseases
PT3965742T (en) Systemic formulation of a pyridinone derivate for tg2-related diseases
IL297081A (en) Pharmaceutical formulation
CA206443S (en) Drug applicator
EP4069251A4 (en) Salts and polymorphs of cethromycin for the treatment of disease salts and polymorphs of cethromycin
EP3914332C0 (en) Device for delivering a flowable ingestible medicament into the gastrointestinal tract of a user
IL310515A (en) Therapeutic agent for ischemic disease
IL297080A (en) Pharmaceutical formulation
IL264731A (en) Device for measuring physiological parameters of a subject
GB202100526D0 (en) Pharmaceutical formulation
GB202001439D0 (en) Drug formulations
GB202008127D0 (en) Sterlisation of endoscopes
ZA202212663B (en) Pharmaceutical formulations
GB202216467D0 (en) Pharmaceutical formulation
IL307277A (en) Therapeutic agent for gait disturbance